Starting Semaglutide: Understanding Your First Dose and Beyond for Weight Loss

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection activates GLP-1 receptors in your brain to regulate hunger and blood sugar, with clinical trials showing an average weight loss of 15% over 68 weeks. Many patients feel nervous about their first injection, but understanding the process and what happens in your body can ease that transition. PlexusDx compounded semaglutide starts at $149 per month, with no insurance required and HSA/FSA eligibility, making this proven therapy accessible to more people.

How Semaglutide Works in Your Body

Semaglutide is a GLP-1 receptor agonist—a synthetic hormone that mimics glucagon-like peptide-1, a natural chemical your gut produces after eating. When semaglutide binds to GLP-1 receptors in your hypothalamus, it slows gastric emptying (how fast food leaves your stomach) and increases fullness signals to your brain. This dual action reduces appetite intensity and helps you feel satisfied on smaller portions, making caloric deficit easier to maintain without constant hunger.

The medication also improves how your pancreas releases insulin in response to meals, which can stabilize blood sugar and reduce cravings for sugary or high-fat foods. Unlike restrictive dieting alone, semaglutide addresses the neurological and hormonal drivers of overeating. Most patients report noticing appetite suppression within 3–5 days of their first injection, though individual responses vary based on genetics, metabolism, and starting body weight.

Your First Dose: What to Expect on Day One

PlexusDx administers semaglutide as a subcutaneous injection—meaning the needle goes just under your skin, typically on your abdomen, thigh, or upper arm. Your first dose is intentionally low (usually 0.25 mg) to let your body adjust and minimize side effects. You'll inject once per week on the same day; most patients choose a convenient day like Monday or Friday to build a routine.

Immediately after injection, you may feel a small sting or mild bruising at the injection site, which typically resolves within hours. Some patients experience no noticeable change on day one, while others report reduced appetite within 24–48 hours. Nausea is the most common early side effect, affecting 20–30% of patients in the first 2–3 weeks, but it's usually mild and improves as your body adapts. Keep food choices bland and frequent—small meals every 2–3 hours help settle your stomach while you adjust.

Dose Escalation and Long-Term Adjustments

PlexusDx follows a standard titration schedule: starting at 0.25 mg weekly, then increasing by 0.25 mg every 4 weeks until reaching your therapeutic dose (usually 1.0–2.4 mg weekly, depending on your goals and tolerance). This gradual escalation gives your body time to adapt to appetite suppression and reduces the intensity of side effects. Your dose may need to go up as your body adjusts—your price won't, because PlexusDx charges a flat monthly rate regardless of your dose tier.

Throughout your treatment, PlexusDx tracks your weight loss, appetite changes, and side effect profile to fine-tune your dose. If you plateau after 8–12 weeks at a given dose, a small increase often re-ignites weight loss momentum. Some patients reach their goal at 1.0 mg weekly, while others benefit from higher doses; genetic factors and your starting weight influence your optimal dose. Regular check-ins ensure you're on track and any concerns are addressed before they interfere with your progress.

Managing Side Effects and Staying Compliant

Nausea, constipation, vomiting, and loss of appetite are well-documented with semaglutide, but most resolve within 3–6 weeks as your body acclimates. To minimize nausea: eat smaller, protein-rich meals; stay hydrated; avoid greasy or sugary foods; and take ginger or vitamin B6 supplements (with your doctor's approval). Constipation can be managed with fiber, increased water intake, and gentle exercise like walking. Reversing or skipping a dose is rarely necessary—side effects are temporary, and pushing through is usually more effective than pausing treatment.

Staying compliant with your weekly injection schedule and following PlexusDx's nutrition and exercise guidance dramatically improves outcomes. Patients who miss doses or revert to old eating habits often regain weight quickly once they stop. PlexusDx provides digital tools, clinical support, and personalized insights to keep you motivated and accountable. If side effects become severe, contact your PlexusDx provider immediately—they can adjust your dose or recommend strategies tailored to your needs.

Personalization: Why Genetic Testing Matters

Not every patient responds equally to semaglutide. Some lose weight rapidly, others more slowly; some experience strong appetite suppression, others mild. These differences often stem from genetic variations in how your body processes GLP-1 signaling. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) to identify genetic variants in key pathways like GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)—all linked to weight loss response and appetite regulation.

By mapping 14 metabolic pathways and 150+ genetic insights, PlexusDx can predict whether semaglutide alone is your best choice or whether a dual-compound option like GLP-Squared (semaglutide + tirzepatide) might accelerate your results. Patients with certain FTO variants, for example, may benefit from more aggressive dosing or dual therapy, while those with high GLP1R sensitivity often succeed at lower doses. This personalized approach saves time and money by helping you find your optimal medication and dose faster.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does semaglutide work immediately, or does it take weeks to see results?

Most patients notice reduced appetite within 3–7 days of their first injection, though weight loss typically becomes measurable after 2–4 weeks. Clinical trials show an average loss of 5–10 pounds in the first month, accelerating as your dose increases. Individual results vary based on genetics, starting weight, and adherence to nutrition and exercise recommendations.

What is the clinical evidence that semaglutide causes weight loss?

The landmark STEP trials demonstrated that patients on semaglutide 2.4 mg weekly lost an average of 15% of body weight over 68 weeks, compared to 2.4% in the placebo group. Real-world data from PlexusDx patients aligns with these results, with most achieving 10–20% weight loss within 6 months when combined with lifestyle modifications.

How much does semaglutide injection cost at PlexusDx?

PlexusDx compounded semaglutide injection starts at $149 per month with a flat monthly fee—your dose may increase, but your price won't. The medication is HSA/FSA eligible, requires no insurance, and comes from licensed 503A compounding pharmacies. PlexusDx serves all 50 states.

Are there serious safety concerns with semaglutide for weight loss?

Semaglutide is well-tolerated in clinical use, with nausea and constipation being the most common side effects. Serious risks (pancreatitis, gallbladder issues, medullary thyroid cancer) are rare and occur in specific populations; PlexusDx screens for contraindications during your initial consultation. Always report severe symptoms to your provider immediately.

Will the Precision Peptide Genetic Test tell me if semaglutide is right for me?

The Precision Peptide Genetic Test identifies genetic variants affecting GLP-1 signaling, appetite regulation, and fat metabolism. These insights help PlexusDx predict your likely response to semaglutide alone versus dual-compound options like GLP-Squared, personalizing your treatment for faster, more sustainable results.

Related Reading

• Semaglutide Starting Dose
• Semaglutide For Weight Loss 2
• Semaglutide Tablets For Weight Loss
• Semaglutide Pills For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.